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ABSTRACT 
Gastrointestinal diseases significantly affect millions of persons inducing a highly significant economical impact comprising health care costs and 
work absenteeism, in addition to patient’s decreased quality of life. The causes of general gastrointestinal problem may be malabsorption 
disorder, gastroenteritis, colitis and ulcer in the stomach or small intestine. Alternatively the problem may be linked to diet, stress, sedentary 
lifestyle, food tolerance or allergy, medication etc.  
The present study aimed to assess the current gastrointestinal drug prescribing pattern in the gastrointestinal diseases. This study was 
performed in Sri Aurobindo hospital, Indore in the outdoor patients and indoor patients in gastrointestinal department.  
This study was done on prescriptions of patients having gastrointestinal diseases indicates that the most common age group to the diseases is 
51-60 years. Gastrointestinal disease most commonly occurs in male as compare to female. Less number of cases were seen in the age group of 
70 yrs-80 yrs. In cases of severe ailments, the number of gastrointestinal drug per prescription even exceeded more than 6-10. 
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1.  INTRODUCTION 
Gastrointestinal diseases are those that affect any section of 
the gastrointestinal tract, from oesophagus to the rectum, 
and the accessory digestive organ liver, gallbladder and 
pancreas. Various gastrointestinal diseases categorized by 
upper and lower GI tract and liver, Gastritis is a common 
condition which occurs when an imbalance between the 
corrosive action of gastric juice and the protective effect of 
mucus on the gastric mucosa develops. The amount of 
mucus in the stomach is insufficient to protect the surface 
epithelium from the destructive effects of hydrochloric 
acid.1   
Gastroesophageal reflux disease develops when the reflux 
of stomach contents in the oesophagus causes chronic 
symptoms (such as heartburn, regurgitation, occasionally 
sore throat and cough) and mucosal damage. Gastro 
oesophageal reflux disease, or GERD, is a digestive disorder 
that affects the lower oesophageal sphincter (LES), the ring 
of muscle between the oesophagus and stomach. Many 
people, including pregnant women, suffer 
from heartburn or acid indigestion caused by GERD.  Reflux 
means to flow back or return. Therefore, gastro 
oesophageal reflux is the return of the stomach's contents 
back up into the oesophagus.  
Peptic ulcer are open sores that develop on the inside lining 
of stomach and upper portion of small intestine .The most 
common symptoms of peptic ulcer is stomach pain. Peptic 
ulcer include: Gastric ulcers that occur on the inside of the 
stomach. Duodenal ulcer that occurs on the inside of the 
upper portion of small intestine (duodenum).2                     
Pancreatitis is pathological swelling and inflammation of 
the pancreas, which is an organ that is important to 
digestion and regulation of blood sugar. There are two 
types of pancreatitis: acute and chronic .Acute pancreatitis 
generally develops suddenly and it is usually short term. 
Chronic pancreatitis which typically develops after multiple 
episodes of acute pancreatitis, and it is usually long term.3 
Constipation occurs when bowel movement becomes less 
frequent or difficult. Going longer than three days without a 
bowel movement is not common. After three days, the stool 
or feces hardens and becomes difficult to pass. Constipation 
is usually caused by inadequate "roughage" or fibre in the 
diet, or a disruption of the regular routine or diet. 
Constipation causes a person to strain during a bowel 
movement. It might include small, hard stools, and 
sometimes causes anal problems such as fissures and 
haemorrhoids. Constipation is rarely the sign of a more 
serious medical condition .4 
Irritable Bowel Syndrome is characterized most commonly, 
by cramping, abdominal pain, bloating, constipation and 
diarrhoea.  Ulcerative is a chronic inflammatory disease of 
the mucosa of the colon and rectum which may ulcerate 
and become infected. It usually occurs in young adults and 
begins in the rectum and sigmoid colon. From there it may 
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spread to involve a variable proportion of the colon and, 
sometimes, the entire colon. Alcohol liver disease is damage 
to the liver and its function due to alcohol abuse. Alcoholic 
liver disease occurs after years of heavy drinking. Over 
time, scarring and cirrhosis can occurs. Cirrhosis is the final 
phase of alcoholic liver disease.5-7         
2.  AIMS AND OBJECTIVES 
Gastrointestinal diseases significantly affect millions of 
persons inducing a highly significant economical impact 
comprising health care costs and work absenteeism, in 
addition to patient’s decreased quality of life. 
Gastrointestinal disease are common and often associated 
with adverse outcomes among the critically ill 
patients.30The causes of general gastrointestinal problem 
may be malabsorption disorder, gastroenteritis, colitis and 
ulcer in the stomach or small intestine. Alternatively the 
problem may be linked to diet, stress, sedentary lifestyle, 
food tolerance or allergy, medication etc.  
The present study aimed to assess the current 
gastrointestinal drug prescribing pattern in the 
gastrointestinal .diseases. This study was performed in Sri 
Aurobindo hospital, Indore in the outdoor patients and 
indoor patients in gastrointestinal department. Sri 
Aurobindo Hospital is attached to the medical college (Sri 
Aurobindo Institute of Medical Sciences).                                                                                                                
3.  MATERIALS AND METHOD                                                                                                      
The present study was performed using prescription of 100 
patients suffering from different GI problems at Sri 
Aurobindo Hospital, Indore. 
3.1   Patients Data Collection Form   
 Patients from various age group with different types of 
gastrointestinal diseases have been selected for the study. 
Patient’s data such as the age, name, gender and data on 
prescribed drugs that include drug name, dosages form, 
route of administration, most prescribed drug etc. were 
recorded on a customized data collection sheet in a 
systematic approval manner. Each drug was counted only 
once without considering any change in the regimen. 
3.2    Period of study 
 The study performed using prescription of 100 patients in 
Sri Aurobindo hospital suffering from gastrointestinal 
diseases. The study conducted in gastrointestinal, 
inpatients and outpatient departments. This study is based 
on hospital prospective and observational study conducted 
in Sri Aurobindo hospital, Indore from period of august to 
November 2016 














4.   RESULTS & DISCUSSION 
The present study includes 100 prescriptions. Different 
data related to the gastrointestinal patients admitted in the 
hospital in outpatient and inpatients department were 
carefully noted and studied. 
Table 1 indicates that out of the 100 prescriptions of 
gastrointestinal drugs studied, it was found that 78% were 
for male and 22% were for female indicating that for male 
patients were predominated over female patients for the 
occurrence of gastrointestinal diseases. It also indicates 
that maximum patients with gastrointestinal diseases were 
from the age group of 51 to 60 years followed by the age 
group of 31 to 40 years in Table-1 therefore interpreted 
that the gastrointestinal diseases were commonly 
occurrence in middle age people.  
Greater prevalence in this age group may be due to 
sedentary life style of people and unhygienic practise by 
people. Contact with someone who has the virus 
.Contaminated food or water Unwashed hands after going 
to the bathroom or changing a diaper. It may also be 
because of consumption of health hazards like smoking, 
alcohol and drugs. 31 
     
 
Table 1: Age and Sex distribution of gastrointestinal of gastrointestinal disease patients 
Age group 
(year) 
Male Female total 
15-20 4 2 6 
21-30 12 - 12 
31-40 18 6 28 
41-50 10 2 12 
51-60 22 10 32 
61-70 10 2 6 
71-80 2 - 2 
81 ABOVE - 2 2 
TOTAL 78 22 100 
 
  Sri Aurobindo Institute Of Pharmacy 
1. Patients information 
      Name: 
      Age: 
      Gender: 
2.    Diseases information 
Diseases:                                                                            
2.  Drugs prescription 
Name of drug: 
Dose: 
 
Patidar et al                                                                                                                Journal of Drug Delivery & Therapeutics. 2018; 8(6-A):28-32 













































Figure 1: Age and sex distribution of gastrointestinal patients 
Table 2 indicated that out of 100 patients of gastrointestinal disease, 78 patients (78%) were male and 22 patients (22%) belong 
to female gender. It was found that male patients were more affected by the gastrointestinal disease than in comparisons with 
female patients. 
Table 2: Gender wise distribution 
Gender No of patients % of patients 
Male 78 78% 
Female 22 22% 
 
 
Figure 2: Gender wise distribution 
Table 3 denoted the total number of drug per prescription. It also indicated that out of 100 patients, 84 patients were prescribed 
with 6 - 10 medicines (84%) per prescription followed by 5 medicines 82%) per prescription and >10 (32%) number of drug  
per prescription so it was found that the patients were prescribe mostly with the drugs from 6-10 no of drug 
Table 3:  Number of drug per prescription 
Number of drug Number of patients Total Percentage 
 Male female   
0-5 60 22 82 82% 
6-10 64 20 84 84% 
>10 28 4 32 32% 
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    Figure 3: Number of drugs per prescription 
 
Data shown in Table 4 indicated that among the different 
gastrointestinal drugs prescribed, composition and dosage 
form of drug. Table 4 clearly indicate that the higher number 
of patients received Rablet (92%) followed by Emest (44%).  
Nausea and vomiting is a common and distressing 
complication for patients with critical illness. Emest (44%) 
was the frequently utilized anti-emetic agent. Emeset was 
preferred probably due to better efficacy and safe. The major 
route of administration was intravenous route. Lactihep was 
the most common laxative prescribed among the critically ill 
patients in the present.  
Several studies showed that Rablet (rabeprazole) category of 
proton pump inhibitor has been most widely used due to 
safe drug for the treatment of gastric acidity and gastro-
intestinal reflux disease. It works by blocking the action of 
proton pump in the stomach which is responsible for the 
production of excessive acid. It further reduces the acid 
production It also treat stomach, intestine ulcer and 
pancreatitis diseases, Zollinger Ellison Syndrome which is a 
diseases associated with the excessive acid production .The 
present study also that a Emeset injection (ondansetron) 
category of Antiemetic is most frequently prescribed for the 
treatment of Nausea and vomiting. Emeset drug works on 
small intestine and brain that controls vomiting or nausea.
 
Table 4: Percentage of drugs prescribed 
Name of drug Dosages form Number of times 
prescribed drug 
Percentage of total drug 
prescribed 
RABLET I/V(20MG) 92 92% 
EMEST I/V(4MG) 44 44% 
LACTIHEP SYP(30ML) 28 28% 
H.ALBUMIN I/V(100ML) 16 16% 
ZINCOVIT TABLET(1G) 16 16% 
RCIFAX TABLET( 350MG) 12 12% 
PANTOCID TABLET 8 8% 
 
 
    Figure 4: Percentage of drugs prescribed 
Figure 4 percentage of drug prescribed is Rablet (I/V20mg) Emest (I/V4mg), lactihep (I/V 30ml), H.Albumin (I/V 100ml), 
Zincovit (tablet1g), Rcifax (tablet 350mg), Pantocid (tablet8mg). 
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5.     CONCULSION                                                                                                                    
Gastrointestinal diseases are most common in India. It 
includes wide variety of problem ranging from acidity to 
ulcers and many more. Many drugs with different brand 
name is available in the market to treat theses 
gastrointestinal (GIT) related problems. This study on 
prescription of 100 patients having gastrointestinal diseases 
indicates that the most common age group to the diseases is 
51-60 years. Gastrointestinal disease most commonly occurs 
in male as compare to female. Less number of cases were 
seen in the age group of 70 yrs-80 yrs. In cases of severe 
ailments, the number of gastrointestinal drug per 
prescription even exceeded more than 6-10. From the data 
collected it was observed that among the gastrointestinal 
drugs were found to be prescribed in following order: 
RABLET > EMESET > LACTIHEP > H.ALBUMIN > ZINCOVIT > 
RCIFAX > PANTOCID Among the drugs, rablet was found to 
be the most common gastrointestinal drugs prescribed to 
treat gastrointestinal diseases like pancreatitis disease 
(chronic and acute) chronic liver disease, liver abscess, and 
abdomen pain. Emeset was found to be the second most 
common gastrointestinal drugs prescribed to treatment of 
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